Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Volume 105, Issue 10, Pages -
Publisher
The Endocrine Society
Online
2020-08-16
DOI
10.1210/clinem/dgaa526
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pituitary-Tumor Endocrinopathies
- (2020) Shlomo Melmed NEW ENGLAND JOURNAL OF MEDICINE
- An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies
- (2020) Maria Fleseriu et al. Pituitary
- Acromegaly
- (2019) Annamaria Colao et al. Nature Reviews Disease Primers
- A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
- (2019) Andrea Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider
- (2019) Eliza B. Geer et al. Pituitary
- How are growth hormone and insulin-like growth factor-1 reported as markers for drug effectiveness in clinical acromegaly research? A comprehensive methodologic review
- (2018) Michiel J. van Esdonk et al. Pituitary
- Systemic complications of acromegaly and the impact of the current treatment landscape: an update
- (2018) Mônica R Gadelha et al. ENDOCRINE REVIEWS
- A Consensus Statement on acromegaly therapeutic outcomes
- (2018) Shlomo Melmed et al. Nature Reviews Endocrinology
- Lanreotide Autogel 120 mg at extended dosing intervals in patients with acromegaly biochemically controlled with octreotide LAR: the LEAD study
- (2015) Sebastian JCMM Neggers et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly
- (2015) Christian J Strasburger et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Safety and Efficacy of Oral Octreotide in Acromegaly: Results of a Multicenter Phase III Trial
- (2015) Shlomo Melmed et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Reference Intervals for Insulin-like Growth Factor-1 (IGF-I) From Birth to Senescence: Results From a Multicenter Study Using a New Automated Chemiluminescence IGF-I Immunoassay Conforming to Recent International Recommendations
- (2014) Martin Bidlingmaier et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly Clinical Trial Methodology Impact on Reported Biochemical Efficacy Rates of Somatostatin Receptor Ligand Treatments: A Meta-Analysis
- (2014) John D. Carmichael et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Acromegaly: An Endocrine Society Clinical Practice Guideline
- (2014) Laurence Katznelson et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pasireotide Versus Octreotide in Acromegaly: A Head-to-Head Superiority Study
- (2014) A. Colao et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Expert consensus document: A consensus on the medical treatment of acromegaly
- (2014) Andrea Giustina et al. Nature Reviews Endocrinology
- A Novel Suspension Formulation Enhances Intestinal Absorption of Macromolecules Via Transient and Reversible Transport Mechanisms
- (2014) Shmuel Tuvia et al. PHARMACEUTICAL RESEARCH
- Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, Phase III study
- (2014) Michael Sheppard et al. Pituitary
- American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly - 2011 Update: Executive Summary
- (2013) Laurence Katznelson et al. Endocrine Practice
- Efficacy and Safety of an Octreotide Implant in the Treatment of Patients With Acromegaly
- (2013) Carla Chieffo et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Automated 22-kD Growth Hormone-Specific Assay without Interference from Pegvisomant
- (2012) J. Manolopoulou et al. CLINICAL CHEMISTRY
- Oral Octreotide Absorption in Human Subjects: Comparable Pharmacokinetics to Parenteral Octreotide and Effective Growth Hormone Suppression
- (2012) S. Tuvia et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Surgery and Radiosurgery for Acromegaly: A Review of Indications, Operative Techniques, Outcomes, and Complications
- (2012) Yvette Marquez et al. International Journal of Endocrinology
- Discontinuation of octreotide LAR after long term, successful treatment of patients with acromegaly: is it worth trying?
- (2011) Claudia Ramírez et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Comparison of octreotide LAR and lanreotide autogel as post-operative medical treatment in acromegaly
- (2011) Yasemin Tutuncu et al. Pituitary
- A Consensus on Criteria for Cure of Acromegaly
- (2010) A. Giustina et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Monitoring of acromegaly: what should be performed when GH and IGF-1 levels are discrepant?
- (2009) Pamela U. Freda CLINICAL ENDOCRINOLOGY
- Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly
- (2009) Roberto Salvatori et al. Pituitary
- Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension
- (2009) Shlomo Melmed et al. Pituitary
- Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48weeks in patients with acromegaly
- (2008) Philippe Chanson et al. CLINICAL ENDOCRINOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More